Concurrent Chemo- Radiobrachytherapy with Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer

OBJECTIVE: Cervical carcinoma is the third most common gynecologic cancer, after ovarian and uterine cancers in Iran. The aim of this study was to evaluate the efficacy (response rate) and toxicity of adding Medium Dose Rate (MDR) brachytherapy with concurrent chemotherapy to External Beam Radiother...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghili, Mahdi, Andalib, Bahram, Moghaddam, Zhaleh Karimi, Safaie, Afsaneh Maddah, Hashemi, Farnaz Amoozgar, Darzikolaie, Nima Mousavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291044/
https://www.ncbi.nlm.nih.gov/pubmed/30360600
http://dx.doi.org/10.22034/APJCP.2018.19.10.2745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291044/
https://www.ncbi.nlm.nih.gov/pubmed/30360600
http://dx.doi.org/10.22034/APJCP.2018.19.10.2745

Ejemplares similares